Nurix Therapeutics Inc
(NRIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 11-2019 | 08-2019 | 05-2019 | 11-2018 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | N/A | 0 | 0 | 25,591 |
| Marketable Securities | N/A | 0 | 0 | 13,448 |
| Other current assets | 0 | 0 | 0 | 1,615 |
| TOTAL | $N/A | $0 | $0 | $40,654 |
| Non-Current Assets | ||||
| PPE Net | N/A | N/A | N/A | 13,093 |
| Other Non-Current Assets | 0 | 0 | 0 | 321 |
| TOTAL | $N/A | $N/A | $N/A | $13,414 |
| Total Assets | $N/A | $0 | $0 | $45,397 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 1,297 |
| Accrued Expenses | N/A | 0 | 0 | 3,115 |
| Other current liabilities | N/A | 0 | 0 | 28,420 |
| TOTAL | $N/A | $0 | $0 | $32,832 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 49,412 |
| TOTAL | $N/A | $N/A | $N/A | $49,412 |
| Total Liabilities | $N/A | $0 | $0 | $82,244 |
| Shareholders' Equity | ||||
| Common Shares | N/A | 0 | 0 | 3 |
| Retained earnings | N/A | 0 | 0 | -38,757 |
| Other shareholders' equity | 0 | 0 | 0 | -4 |
| TOTAL | $N/A | $0 | $0 | $-36,847 |
| Total Liabilities And Equity | $0 | $0 | $0 | $45,397 |